Bork, K; Hardt, J; Staubach-Renz, P et al.
Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective studyORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY. Bd. 112. H. 1. 2011 S. 58-64
Rudolph, B; Groffik, A; Muller-Brenne, T et al.
Severe colitis with pyoderma gangrenosum after ipilimumab treatment in a melanoma patient with colostomy - a therapeutic challengeJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. H. 9. 2011 S. 788-788
Kautz-Neu, K; Kostka, LS; Dinges, S et al.
Skin mast contribute to Th1-driven protection against Leishmania major in vivoJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. H. 10. 2011 S. E3-E3
Niggemann, B; Beyer, K; Erdmann, S et al.
Standardisation of oral provocation tests on suspicion of food allergyALLERGOLOGIE. Bd. 34. H. 9. 2011 S. 467-479
Muller-Brenne, T; Rudolph, B; Schmidberger, H et al.
Successful Therapy of a cerebral metastasized malign Melanoma by Whole-Brain-Radiation and Therapy with IpilimumabJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. H. 9. 2011 S. 787-788
Luckey, U; Maurer, M; Schmidt, T et al.
T cell killing by tolerogenic dendritic cells protects mice from allergyJOURNAL OF CLINICAL INVESTIGATION. Bd. 121. H. 10. 2011 S. 3860-3871
Trojandt, S; Grabbe, S; Reske-Kunz, AB et al.
The anti-tumor agent topotecan has an impact on the activation of human monocyte derived dendritic cellsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 78-78
Liesenfeld, O; Parvanova, I; Zerrahn, J et al.
The IFN-gamma-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular PathogensPLOS ONE. Bd. 6. H. 6. 2011 S. -
von Stebut, E; Steinbrink, K
Toxic dermatitis in patients treated with Taxotere (docetaxel): Three case reportsINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS. Bd. 49. H. 1. 2011 S. 1-2
Groffik, A; Rudolph, B; Weirich, O et al.
Tumor Lysis Syndrome being treated by highly selective BRAF-Inhibitor in a Patient with metastisized malign MelanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 9. H. 9. 2011 S. 785-785